Journal of Public Health Policy

, Volume 29, Issue 1, pp 86–104 | Cite as

The Impact of Corporate Practices on Health: Implications for Health Policy

  • Nicholas FreudenbergEmail author
  • Sandro Galea


Although corporate practices play a substantial role in shaping health and health behavior, public health researchers have rarely systematically studied these practices as a social determinant of health. We consider case studies of three products – trans fat, a food additive and a preservative; Vioxx, a pain killer; and sports utility vehicles – to illustrate the role of corporate policies and practices in the production of health and disease and the implications for health policy. In recent years, public health advocates, researchers, and lawyers have used strategies to reduce the adverse health impact of corporate practices. Systematic analysis of these experiences yields insights that can guide the development of health policies that increase opportunities for primary prevention by discouraging harmful corporate practices.


health policy corporate practices social determinants health promotion 


  1. Wiist WH . Public health and the anticorporate movement: rationale and recommendations. Am J Public Health. 2006;96:1370–1375.CrossRefGoogle Scholar
  2. Geiser K, Rosenberg BJ . The social context of occupational and environmental healthIn: Levy BS, editors, Occupational and Environmental Health: Recognizing and Preventing Disease And Injury. 5th Edition. Philadelphia, PA: Lippincott Williams & Wilkins; 2006, pp. 21–38.Google Scholar
  3. LaVeist TA . Disentangling race and socioeconomic status: a key to understanding health inequalities. J Urban Health. 2005;82 (2):iii26–iii34.Google Scholar
  4. Mechanic D . Disadvantage, inequality, and social policy. Health Aff (Millwood). 2002;21 (2):48–59.CrossRefGoogle Scholar
  5. Wyatt SB, Williams DR, Calvin R, Henderson FC, Walker ER, Winters K . Racism and cardiovascular disease in African Americans. Am J Med Sci. 2003;325 (6):315–331.CrossRefGoogle Scholar
  6. McGinnis JM, Williams-Russo P, Knickman JR . The case for more active policy attention to health promotion. Health Aff (Millwood). 2002;21 (2):78–93.CrossRefGoogle Scholar
  7. Adler NE, Newman K . Socioeconomic disparities in health: pathways and policies. Health Aff (Millwood). 2002;21 (2):60–76.CrossRefGoogle Scholar
  8. Marmot M . Social determinants of health inequalities. Lancet. 2005;365 (9464):1099–1104.CrossRefGoogle Scholar
  9. Wilkinson RG, Pickett KE . Income inequality and population health: a review and explanation of the evidence. Soc Sci Med. 2006;62 (7):1768–1784.CrossRefGoogle Scholar
  10. McKeown T . The Role of Medicine: Dream, Mirage, Or Nemesis?. Princeton, NJ: Princeton University Press; 1979.Google Scholar
  11. Link B, Phelan J . Fundamental sources of health inequalitiesIn: Mechanic D, Rogut LB, Colby DC and Knickman JR, editors Policy Challenges in Modern Health Care. New Brunswick, NJ: Rutgers University Press; 2005.Google Scholar
  12. Freudenberg N. Public health advocacy to change corporate practices: implications for health education practice and research. Health Ed Behav. 2005;32 (3):298–319.Google Scholar
  13. Willett WC, Stampfer MJ, Manson JE, Colditz GA, Speizer FE, Rosner BA, Sampson LA, Hennekens CH . Intake of trans fatty acids and risk of coronary heart disease among women. Lancet. 1993;341 (8845):581–585.CrossRefGoogle Scholar
  14. Ascherio A, Hennekens CH, Buring JE, Master C, Stampfer MJ, Willett WC . Trans fatty acids intake and risk of myocardial infarction. Circulation. 1994;89 (1):94–101.CrossRefGoogle Scholar
  15. Clandinin MT, Wilke MS . Do trans fatty acids increase the incidence of type 2 diabetes? Am J Clin Nutr. 2001;73 (6):1001–1002.Google Scholar
  16. Salmeron J, Hu FB, Manson JE, Stampfer MJ, Colditz GA, Rimm EB, Willett WC . Dietary fat intake and risk of type 2 diabetes in women. Am J Clin Nutr. 2001;73 (6):1019–1026.Google Scholar
  17. Ascherio A, Stampfer MJ, Willett WC . Background and Scientific Review Trans Fatty Acids and Coronary Heart Disease. Boston MA: Departments of Nutrition and Epidemiology, Harvard school of Public Health, The Channing Laboratory, Department of Medicine, Brigham and Women's Hospital; 1999.Google Scholar
  18. Anonymous. Trans fatty acids and coronary heart disease risk. Report of the expert panel on trans fatty acids and coronary heart disease. Am J Clin Nutr. 1995;62 (3):655S–708S.Google Scholar
  19. Weinraub J . Getting the fat out. Washington Post 12 November 2003, F1.Google Scholar
  20. Food and Drug Administration. Food labeling: trans fatty acids in nutrition labeling, nutrient content claims and health claims. Federal Register. 1999;64:62746.Google Scholar
  21. Institute of Medicine (US) Committee on Prevention of Obesity in Children and Youth, Koplan J, Kraak VI, Liverman CT. Institute of Medicine Board on Health Promotion and Disease Prevention, Institute of Medicine. Food and Nutrition Board, I. NetLibrary, Preventing Childhood Obesity. 2005;414.Google Scholar
  22. Simons J, Stipp D . Will Merck survive Vioxx? Fortune. 2004;150 (9):90–97.Google Scholar
  23. Topol EJ . Failing the public health--rofecoxib, Merck, and the FDA. N Engl J Med. 2004;351 (17):1707–1709.CrossRefGoogle Scholar
  24. Hawthorne F . The Merck Druggernaut: The Inside Story of a Pharmaceutical Giant. Hoboken, NJ: Wiley and Sons; 2003.Google Scholar
  25. Brown D . Promise and peril of Vioxx casts harsher light on new drugs. Washington Post. 3 October 2004 A14.Google Scholar
  26. Berenson A . In training video, Merck said Vioxx did not increase risk of heart attack. New York Times. 21 July 2005 C4.Google Scholar
  27. Berenson A, Harris G, Meier B, Pollack A . Despite warnings, drug giant took long path to Vioxx recall. New York Times. 14 November 2005.Google Scholar
  28. Associated Press. Vioxx data suggest risk started earlier. New York Times. 19 May 2006.Google Scholar
  29. Bradsher K . High and Mighty SUVs: The World's most Dangerous Vehicles and How They Got that Way. New York, NY: Public Affairs; 2002.Google Scholar
  30. Coate D, VanderHoff J . The truth about light trucks. Regulation. 2001;24 (1):22.Google Scholar
  31. National Highway Traffic Safety Administration. US Department of Transportation. Federal Motor Vehicle Safety Standards: Roof Crush Resistance, 49 CFR Part 571. Docket No. NHTSA-2005-22143. RIN 2127-AG51. 2005.Google Scholar
  32. White MJ . The “arms race” on American roads: the effect of sports utility vehicles and pickup trucks on traffic safety. J Law Econ. 2004;47:333–353.CrossRefGoogle Scholar
  33. Environmental Protection Agency. Control of Emissions from New and in-use Highway Vehicles and Engines. 40 CFR 86, 2004.Google Scholar
  34. Haines A, Patz JA . Health effects of climate change. JAMA 291 (1):99–103.Google Scholar
  35. Hakim D . Used S.U.V.'s come loaded, with safety concerns. New York Times, 26 June 2005.Google Scholar
  36. Doyle J . Taken for a Ride: Detroit's Big Three and the Politics of Pollution. New York, NY: Four Walls Eight Windows; 2000.Google Scholar
  37. Claybrook J . Profit-driven myths and severe public damage: the terrible truth about SUVs. Testimony before the senate committee on commerce, science and transportation. Available at, accessed 25 June 2006.
  38. Nestle M . Food Politics: How the Food Industry Influences Nutrition and Health. Berkeley, CA: University of California Press; 2002.Google Scholar
  39. Nestle M . What to Eat an Aisle-to-Aisle Guide to Savvy Food Choices And Good Eating. New York, NY: North Point Press; 2006.Google Scholar
  40. Hemenway D . Private Guns, Public Health. Ann Arbor: University of Michigan Press; 2004.CrossRefGoogle Scholar
  41. Angell M . The Truth about the Drug Companies: How they Deceive us and What to do About it. New York: Random House; 2004.Google Scholar
  42. Schroeder SA . Tobacco control in the wake of the 1998 master settlement agreement. N Engl J Med. 2004;350:293–301.CrossRefGoogle Scholar
  43. Chung PJ, Garfield CF, Rathouz PJ, Lauderdale DS, Best D, Lantos J . Youth targeting by tobacco manufacturers since the master settlement agreement. Health Aff (Millwood). 2002;21:254–263.CrossRefGoogle Scholar
  44. Mosher JF, Johnsson D . Flavored alcoholic beverages: an international marketing campaign that targets youth. J Public Health Policy. 2005;26 (3):326–342.CrossRefGoogle Scholar
  45. Young LR, Nestle M . Expanding portion sizes in the US marketplace: implications for nutrition counseling. J Am Diet Assoc. 2003;103 (2):231–234.CrossRefGoogle Scholar
  46. Bray GA, Nielsen SJ, Popkin BM . Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr. 2004;79 (4):537–543.Google Scholar
  47. Bray GA, Paeratakul S, Popkin BM . Dietary fat and obesity: a review of animal, clinical and epidemiological studies. Physiology & Behavior. 2004;83 (4):549–555.CrossRefGoogle Scholar
  48. Kluger R . Ashes to Ashes America's Hundred-Year Cigarette War, the Public Health and the Unabashed Triumph of Philip Morris. New York: Vintage; 1996.Google Scholar
  49. Siebel BJ . The case against the gun industry. Public Health Rep. 2000;115:410–418.CrossRefGoogle Scholar
  50. Center for Responsive Politics. Open secrets. Available at, accessed 3 June 2006.
  51. Birnbaum JH . The road to riches is called K street. Washington Post. 22 June 2005, A1.Google Scholar
  52. Galbi DA . Some economics of personal activity and implications for the digital economy. First Monday. 2001;6 (7). Available at, accessed 11 September 2006.
  53. US General Accounting Office. Public Education: Commercial Activities in Schools GAO/HEHS-00-156. 2000.Google Scholar
  54. Barstow D, Gerstein R, Stein R . US rarely seeks charges for deaths in workplace. New York Times. 22 December 2003: A1.Google Scholar
  55. Labaton S . Silent tort reform' is overriding states' powers. New York Times. March 2006: C5.Google Scholar
  56. Shull R, Smith G . The Bush Regulatory Record a Pattern of Failure. Washington, D.C.: OMB Watch; 2004.Google Scholar
  57. National Restaurant Association. State frivolous-lawsuit legislation. Available at, accessed 11 September 2006.
  58. Story M, French S . Food advertising and marketing directed at children and adolescents in the US. Int J Behav Nutr Phys Act. 2004;1 (1):3.CrossRefGoogle Scholar
  59. Walker R . Consumed; fitting in. New York Times Magazine. 2006, 30 April: 22.Google Scholar
  60. McGinnis JM, Foege WH . Actual causes of death in the United States. JAMA. 1993;270 (18):2207–2212.CrossRefGoogle Scholar
  61. Mokdad AH, Marks JS, Stroup DF, Gerberding JL . Actual causes of death in the United States, 2000. JAMA. 2004;291 (10):1238–1245.CrossRefGoogle Scholar
  62. Wilkinson RG . Health, hierarchy, and social anxiety. Ann N Y Acad Sci. 1999;896:48–63.CrossRefGoogle Scholar
  63. Marmot MG . Status syndrome: a challenge to medicine. JAMA. 2006;295 (11):1304–1307.CrossRefGoogle Scholar
  64. Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC . Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med. 2000;343 (1):16–22.CrossRefGoogle Scholar
  65. Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, Willett WC . Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med. 2001;345 (11):790–797.CrossRefGoogle Scholar
  66. Weber M . From Max Weber: Essay in Sociology. New York, NY: Oxford University Press; 1946.Google Scholar
  67. Cockerham WC . Health lifestyle theory and the convergence of agency and structure. Journal of Health and Social Behavior. 2005;46 (1):51–67.CrossRefGoogle Scholar
  68. Williams SJ . Theorizing class, health and lifestyles: can Bourdieu help us? Sociol Health Illn. 1995;17:577–604.CrossRefGoogle Scholar
  69. Sullum J . For Your Own Good: The Anti-Smoking Crusade and the Tyranny of Public Health. New York, NY: Free Press; 1998.Google Scholar
  70. Stiglitz JE . Globalization and its Discontents. New York, NY: W. W. Norton & Company; 2003.Google Scholar
  71. Balko R . Private matters and ‘public health’. Available at, accessed 26 June 2006.
  72. Variyam JN, Cawley J . Nutrition Labels and Obesity. NBER Working Paper No 11956. 2006.Google Scholar
  73. Avorn J, Shrank W . Highlights and a hidden hazard--the FDA's new labeling regulations. N Engl J Med. 2006;354 (23):2409–2411.CrossRefGoogle Scholar
  74. Stiglitz J . On Liberty, the Right to Know, and Public Discourse: The Role of Transparency in Public Life. Oxford: Oxford Amnesty Lecture; 1999.Google Scholar
  75. Chaloupka FJ, Wakefield M, Czart C . Taxing Tobacco: the impact of Tobacco taxes on cigarette smoking and other Tobacco useIn: Rabin RL and Sugarman SD, editors, Regulating Tobacco. New York, NY: Oxford University Press; 2001.Google Scholar
  76. Chaloupka FJ, Grossman M, Saffer H . The effects of price on alcohol consumption and alcohol-related problems. Alcohol Research & Health. 2002;26 (1):22–34.Google Scholar
  77. Cook PJ, Moore MJ . The economics of alcohol abuse and alcohol-control policies. Health Aff (Millwood). 2002;21 (2):120–133.CrossRefGoogle Scholar
  78. Jacobson MF, Brownell KD . Small taxes on soft drinks and snack foods to promote health. Am J Public Health. 2000;90 (6):854–857.CrossRefGoogle Scholar
  79. Lewis MJ, Wackowski O . Dealing with an innovative industry: a look at flavored cigarettes promoted by mainstream brands. Am J Public Health. 2006;96 (2):244–251.CrossRefGoogle Scholar
  80. Marketing food to children: editorial. Lancet. 2005;366:2064.Google Scholar
  81. Union of Concerned Scientists. Fuel Economy Fraud: Closing the Loopholes that Increase US Oil Dependency. Available at, accessed 11 September 2006.
  82. Mello MM, Studdert DM, Brennan TA . Obesity--the new frontier of public health law. N Engl J Med. 2006;354 (24):2601–2610.CrossRefGoogle Scholar
  83. Parmet WE, Daynard RA . The new public health litigation. Annu Rev Public Health. 2000;21:437–454.CrossRefGoogle Scholar
  84. Lytton TD . Using litigation to make public health policy: theoretical and empirical challenges in assessing product liability, tobacco, and gun litigation. The Journal of Law, Medicine & Ethics : A Journal of the American Society of Law, Medicine & Ethics. 2004;32 (4):556–564.CrossRefGoogle Scholar
  85. Cranor CF . Some legal implications of the precautionary principle: improving information-generation and legal protections. Int J Occup Med Environ Health. 2004;17 (1):17–34.Google Scholar
  86. Richter ED, Laster R . The precautionary principle, epidemiology and the ethics of delay. Int J Occup Med Environ Health. 2004;171:9–16.Google Scholar
  87. Dorfman L, Wallack L, Woodruff K . More than a message: framing public health advocacy to change corporate practices. Health Educ Behav. 2005;32 (3):320–336.CrossRefGoogle Scholar
  88. Wallack L, Lawrence R . Talking about public health: developing America's “second language”. Am J Public Health. 2005;95 (4):567–570.CrossRefGoogle Scholar
  89. Gostin LO, Javitt GH . Health promotion and the first amendment: government control of the informational environment. Milbank Q. 2001;79 (4):547–578.CrossRefGoogle Scholar
  90. Kunkel D . Children and television advertising In: Singer D, Singer J, editors Children and the Media. Thousand Oaks, CA: Sage Publications; 2001.Google Scholar

Copyright information

© Palgrave Macmillan Ltd 2008

Authors and Affiliations

  1. 1.Hunter College, Public HealthNew YorkUSA
  2. 2.University of Michigan, Public HealthAnn ArborUSA

Personalised recommendations